Rexahn Pharmaceuticals, Inc. (AMEX: RNN) is currently trading at 1.34, up .07 or 5.5%. This company is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, and other medical needs. On May 21st, it released its 10-Q Quarterly Report, showing a decrease in net loss from $1,484,802 or $.03 per share for the 3 months ended March 31, 2009 to $1,571,104 or $.02 per share in the same period of 2010.
Wednesday, June 2, 2010
WMM MicroCap Movers (NASDAQ: GOLF) (AMEX: RNN)
Golfsmith International Holdings Inc. (NASDAQ: GOLF) is trading at 4.59, up .30 or 6.99%. Yesterday, it announced that it's hosting another golf club giveaway promotion called "Pick a Pro and Win." In March, the sports equipment retailer refunded customers that bought one of 3 Callaway drivers, after Phil Mickelson won a master's tournament. This time, customers can bet on one of three golfers to win the U.S. Open Golf Championship in Pebble Beach, California- Retief Goosen, Sergio Garcia, or Sean O'Hair- and have the price of one of three new TaylorMade drivers refunded if their player wins. The drivers must be purchased before June 16th at any Golfsmith store across the country.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN) is currently trading at 1.34, up .07 or 5.5%. This company is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, and other medical needs. On May 21st, it released its 10-Q Quarterly Report, showing a decrease in net loss from $1,484,802 or $.03 per share for the 3 months ended March 31, 2009 to $1,571,104 or $.02 per share in the same period of 2010.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN) is currently trading at 1.34, up .07 or 5.5%. This company is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, and other medical needs. On May 21st, it released its 10-Q Quarterly Report, showing a decrease in net loss from $1,484,802 or $.03 per share for the 3 months ended March 31, 2009 to $1,571,104 or $.02 per share in the same period of 2010.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment